Prison Treatment Programs: Glaxo-Wellcome Awards 19 Grants

On September 21 Glaxo Wellcome announced the award of 19 grants, totaling $400,000, to nonprofit organizations "to fund innovative programs focusing on the healthcare needs of incarcerated individuals living with HIV... The grants will support such programs as case management services, outreach services, educational materials and presentations, hotlines, peer-education programs, transition programs and treatment advocacy services." The grants ranged from $10,000 to $40,000. One major purpose of the program is to assure continuity of treatment access when prisoners are released.
The 19 funded proposals were selected from among 92 submitted in response to Glaxo's RFP (see "Prison or Discharge Treatment Programs: Funding Available, Proposals Due June 29," AIDS Treatment News #296, June 5, 1996).